返回
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.（01541.HK）價格
01541.HK 股價走勢圖
IMMUNEONCO-B (01541.HK)
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
HK$5.43
-7.49%
$-0.44
休市： Jan 20, 16:00:00 HKT
關鍵數據
前收市價
$5.88
開盤價
$5.87
當日範圍
$5.38 - $5.88
52週區間
$4.31 - $16.8
交易量
2.4M
平均成交量
2.1M
每股盈餘 (TTM)
-0.93
股息收益率
--
市值
$2.2B
什麼是 IMMUNEONCO-B？
ImmuneOnco Biopharmaceuticals (Shanghai), Inc. operates as an early-stage biopharmaceutical company which develops and commercializes novel cancer immunotherapeutic products. The company is headquartered in Shanghai, Shanghai and currently employs 195 full-time employees. The company went IPO on 2023-09-05. The firm's main businesses include the development of biotechnology for the systemic utilization of innate and adaptive immunity, and the development of next-generation tumor immunotherapies, which primarily focus on the adaptive immune system. The firm's core product IMM01 is an innovative CD47-targeted molecule. The firm mainly operates its businesses in the domestic and overseas markets.